Back to mobile site

Canaccord Genuity maintains a 'Buy' on Exact Sciences (EXAS); Q2 Preview: Unique Opportunity Presented

July 12, 2012 1:21 PM EDT Send to a Friend
Canaccord Genuity maintains a 'Buy' on Exact Sciences (NASDAQ: EXAS) price target of $15.00.

Analyst, Jeffrey Frelick, said, "We ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login